EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bridging Pancreatic Amyloidosis and Neurodegeneration: The Emerging Role of Amylin in Diabetic Dementia

Gourav Shome iD, Ritwick Mondal iD, Shramana Deb, Jayanta Roy iD, Atin Kumar Mandal, Julián Benito-León iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26115021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Gourav Shome und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Bose Institute, Kolkata 700054, India. Hauptthemen laut MEDLINE: Islet Amyloid Polypeptide, Diabetes Mellitus, Type 2, Dementia, Amyloidosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Department of Biotechnology, Government of India, awarded to Atin Kumar Mandal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A hallmark of type 2 diabetes mellitus (T2DM) is the presence of abundant amyloid deposits composed of amyloid polypeptide (amylin) within the pancreatic islets of Langerhans. Given its high prevalence among diabetic individuals, human amylin fibrillization has long been considered a key pathogenic factor in T2DM. Co-secreted with insulin, amylin can misfold and aggregate, inducing β-cell toxicity, impairing insulin secretion, and accelerating disease progression. Emerging evidence also indicates that amylin accumulates in the brains of patients with Alzheimer’s disease, where it may interact with amyloid-β (Aβ) to promote neurodegeneration. Although the underlying mechanisms remain under investigation, amylin aggregates have been shown to disrupt mitochondrial function, trigger endoplasmic reticulum stress, and activate the NLRP3 inflammasome. Additionally, T2DM-associated cerebrovascular alterations may compound cognitive decline. This review, based on a comprehensive literature search across major biomedical databases up to January 2025, synthesizes current evidence on amylin as a molecular link between metabolic and neurodegenerative disorders. We highlight pancreatic β-cell amylin aggregation as a potential early marker of dementia risk in T2DM and examine its relationship with proteostasis-associated proteins. Finally, we discuss emerging diagnostic and therapeutic strategies targeting amylin pathology, offering new perspectives on preventing or delaying neurodegeneration in individuals with T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islet Amyloid PolypeptideDiabetes Mellitus, Type 2DementiaAmyloidosisHumansAnimalsInsulin-Secreting Cells

Stichwörter der Autor:innen

Alzheimer’s diseaseagingamylinamyloid-βdementiaheat shock protein (HSP)human islet amyloid polypeptide (human amylin)proteostasistype 2 diabetes mellitus

Substanzen

Islet Amyloid Polypeptide

Autor:innen und Institutionen

  • Department of Biological Sciences, Bose Institute, Kolkata 700054, India.
  • Department of Neurology, Manipal Group of Hospitals Kolkata, Kolkata 700099, India.
  • Department of Neurology, 12 de Octubre University Hospital, 28041 Madrid, Spain.
  • Group of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain.
  • Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28029 Madrid, Spain.
  • Department of Medicine, Faculty of Medicine, Complutense University, 28040 Madrid, Spain.

ORCID-Profile: Gourav Shome, Ritwick Mondal, Jayanta Roy, Julián Benito-León

Förderung

  • NINDS NIH HHS
  • Department of Biotechnology, Government of India
  • awarded to Atin Kumar Mandal
  • National Institutes of Health
  • Recovery, Transformation, and Resilience Plan of the Spanish Ministry of Science and Innovation
  • fellowships from the Council of Scientific and Industrial Research

Zitieren

APA

Shome, G., Mondal, R., Deb, S., Roy, J., Mandal, A. K., & Benito-León, J. (2025). Bridging Pancreatic Amyloidosis and Neurodegeneration: The Emerging Role of Amylin in Diabetic Dementia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115021

Vancouver

Shome G, Mondal R, Deb S, Roy J, Mandal AK, Benito-León J. Bridging Pancreatic Amyloidosis and Neurodegeneration: The Emerging Role of Amylin in Diabetic Dementia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115021

BibTeX
@article{Shome2025,
  author = {Shome, Gourav and Mondal, Ritwick and Deb, Shramana and Roy, Jayanta and Mandal, Atin Kumar and Benito-León, Julián},
  title = {Bridging Pancreatic Amyloidosis and Neurodegeneration: The Emerging Role of Amylin in Diabetic Dementia},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26115021}
}
Kostenlos starten →